Ozoile Reduces the LPS-Induced Inflammatory Response in Colonic Epithelial Cells and THP-1 Monocytes
Current Issues in Molecular Biology · 05.02.2023 · 45 (2) · 1333-1348
DOI: 10.3390/cimb45020087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 05.02.2023. Verfasst von Maria Paola Bertuccio und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 98125 Messina, Italy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inappropriate activation of immune functions in intestinal epithelial cells can lead to inflammation that is characterized also by infiltration into intestinal tissue of monocytes/macrophages. Current therapies for intestinal inflammation include anti-inflammatory, immunosuppressive and biological drugs. Ozoile (stable ozonides) has been reported to exert anti-inflammatory effects. However, ozonated oil has been used mainly for topical applications and no data are available about its effects on intestinal cells or immune cells. In this study, we evaluated Ozoile effects on human HT-29 colonic cells and THP-1 monocytic cells stimulated with LPS to induce inflammation. HT-29 and THP-1 cells were treated with LPS in the presence/absence of Ozoile for 4 h. Biomarkers of inflammation, some members of tight junctions and the adhesion molecule ICAM were assessed by qRT-PCR. Protein expression was analyzed by Western blotting. The release of TNF-α and IL-1β was measured by ELISA. In HT-29, Ozoile inhibited LPS-induced expression of TNF-α, IL-1β, ZO-1, CLDN1, NOS2 and MMP-2 and increased the expression of Nrf2 and SOD2 antioxidant proteins. In THP-1 cells, the LPS induction of TNF-α, IL-1β and ICAM was counteracted by Ozoile treatment. Our in vitro results demonstrate the effectiveness of Ozoile in reducing the inflammatory response in intestinal and monocytic cells. Further in vivo studies are necessary to confirm its possible use for intestinal inflammatory conditions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 98125 Messina, Italy.
- Unit of Pediatric Surgery, Department of Human Pathology of Adult and Childhood "Gaetano Barresi", University of Messina, 98125 Messina, Italy.
ORCID-Profile: Maria Paola Bertuccio, Salvatore Arena, Alessandra Trainito, Daniela Caccamo, Monica Currò, Carmelo Romeo, Pietro Impellizzeri
Zitieren
APA
Bertuccio, M. P., Rizzo, V., Arena, S., Trainito, A., Montalto, A. S., Caccamo, D., Currò, M., Romeo, C., & Impellizzeri, P. (2023). Ozoile Reduces the LPS-Induced Inflammatory Response in Colonic Epithelial Cells and THP-1 Monocytes. Current Issues in Molecular Biology, 45(2), 1333-1348. https://doi.org/10.3390/cimb45020087
Vancouver
Bertuccio MP, Rizzo V, Arena S, Trainito A, Montalto AS, Caccamo D, et al. Ozoile Reduces the LPS-Induced Inflammatory Response in Colonic Epithelial Cells and THP-1 Monocytes. Current Issues in Molecular Biology. 2023;45(2):1333-1348. doi:10.3390/cimb45020087
BibTeX
@article{Bertuccio2023,
author = {Bertuccio, Maria Paola and Rizzo, Valentina and Arena, Salvatore and Trainito, Alessandra and Montalto, Angela Simona and Caccamo, Daniela and Currò, Monica and Romeo, Carmelo and Impellizzeri, Pietro},
title = {Ozoile Reduces the LPS-Induced Inflammatory Response in Colonic Epithelial Cells and THP-1 Monocytes},
journal = {Current Issues in Molecular Biology},
year = {2023},
volume = {45},
number = {2},
pages = {1333--1348},
doi = {10.3390/cimb45020087}
}
EUVIMED